Cargando…

Morbihan disease: a therapeutic challenge

Morbihan disease is a rare condition characterized by chronic and persistent erythematous solid edema localized on the face. It is believed to be a complication of rosacea and may occur at any stage of the disease. Features of this condition include variable therapeutic response and great refractori...

Descripción completa

Detalles Bibliográficos
Autores principales: Cabral, Fernanda, Lubbe, Lara Caroline, Nóbrega, Monisa Martins, Obadia, Daniel Lago, Souto, Roberto, Gripp, Alexandre Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Dermatologia 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786404/
https://www.ncbi.nlm.nih.gov/pubmed/29364446
http://dx.doi.org/10.1590/abd1806-4841.20174485
_version_ 1783295780499488768
author Cabral, Fernanda
Lubbe, Lara Caroline
Nóbrega, Monisa Martins
Obadia, Daniel Lago
Souto, Roberto
Gripp, Alexandre Carlos
author_facet Cabral, Fernanda
Lubbe, Lara Caroline
Nóbrega, Monisa Martins
Obadia, Daniel Lago
Souto, Roberto
Gripp, Alexandre Carlos
author_sort Cabral, Fernanda
collection PubMed
description Morbihan disease is a rare condition characterized by chronic and persistent erythematous solid edema localized on the face. It is believed to be a complication of rosacea and may occur at any stage of the disease. Features of this condition include variable therapeutic response and great refractoriness. We report a case of a 61-year-old man with rosacea history diagnosed with Morbihan disease, who showed excellent therapeutic response with the combination of deflazacort and oral isotretinoin but developed recurrence after corticosteroid discontinuation. We believe that in severe cases of lymphedema of the face this combination is effective and corticosteroid suspension should be done slowly and gradually.
format Online
Article
Text
id pubmed-5786404
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Sociedade Brasileira de Dermatologia
record_format MEDLINE/PubMed
spelling pubmed-57864042018-02-01 Morbihan disease: a therapeutic challenge Cabral, Fernanda Lubbe, Lara Caroline Nóbrega, Monisa Martins Obadia, Daniel Lago Souto, Roberto Gripp, Alexandre Carlos An Bras Dermatol Case Report Morbihan disease is a rare condition characterized by chronic and persistent erythematous solid edema localized on the face. It is believed to be a complication of rosacea and may occur at any stage of the disease. Features of this condition include variable therapeutic response and great refractoriness. We report a case of a 61-year-old man with rosacea history diagnosed with Morbihan disease, who showed excellent therapeutic response with the combination of deflazacort and oral isotretinoin but developed recurrence after corticosteroid discontinuation. We believe that in severe cases of lymphedema of the face this combination is effective and corticosteroid suspension should be done slowly and gradually. Sociedade Brasileira de Dermatologia 2017 /pmc/articles/PMC5786404/ /pubmed/29364446 http://dx.doi.org/10.1590/abd1806-4841.20174485 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivative License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium provided the original work is properly cited and the work is not changed in any way.
spellingShingle Case Report
Cabral, Fernanda
Lubbe, Lara Caroline
Nóbrega, Monisa Martins
Obadia, Daniel Lago
Souto, Roberto
Gripp, Alexandre Carlos
Morbihan disease: a therapeutic challenge
title Morbihan disease: a therapeutic challenge
title_full Morbihan disease: a therapeutic challenge
title_fullStr Morbihan disease: a therapeutic challenge
title_full_unstemmed Morbihan disease: a therapeutic challenge
title_short Morbihan disease: a therapeutic challenge
title_sort morbihan disease: a therapeutic challenge
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786404/
https://www.ncbi.nlm.nih.gov/pubmed/29364446
http://dx.doi.org/10.1590/abd1806-4841.20174485
work_keys_str_mv AT cabralfernanda morbihandiseaseatherapeuticchallenge
AT lubbelaracaroline morbihandiseaseatherapeuticchallenge
AT nobregamonisamartins morbihandiseaseatherapeuticchallenge
AT obadiadaniellago morbihandiseaseatherapeuticchallenge
AT soutoroberto morbihandiseaseatherapeuticchallenge
AT grippalexandrecarlos morbihandiseaseatherapeuticchallenge